IDXX Earnings & Financial Statements
IDEXX Laboratories, Inc.
$529.01
+$8.70(+1.67%)
45
Overall
35
Value
40
Tech
60
Quality
Market Cap
$41.68B
Volume
824.32K
52W Range
$500.61 - $769.98
Target Price
$717.92
IDXX earnings and financial statements: IDEXX Laboratories, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
IDXX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $4.30B | $3.90B | $3.66B | $3.37B | $3.22B |
| Cost of revenue | $1.64B | $1.52B | $1.47B | $1.36B | $1.33B |
| Operating income | $1.36B | $1.13B | $1.10B | $898.76M | $932.03M |
| EBITDA | $1.51B | $1.27B | $1.22B | $1.01B | $1.04B |
| Net income | $1.06B | $887.87M | $845.04M | $679.09M | $744.85M |
| EPS (diluted) | $13.08 | $10.67 | $10.06 | $8.03 | $8.60 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $3.35B | $3.29B | $3.26B | $2.75B | $2.44B |
| Total liabilities | $1.75B | $1.70B | $1.78B | $2.14B | $1.75B |
| Shareholders’ equity | $1.61B | $1.60B | $1.48B | $608.74M | $689.99M |
| Cash and equivalents | $180.07M | $288.27M | $453.93M | $112.55M | $144.45M |
| Long-term debt | $475.99M | $547.62M | $722.55M | $795.63M | $862.58M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $1.18B | $929.00M | $906.51M | $542.98M | $755.55M |
| Capital expenditure | -$138.23M | -$130.92M | -$133.63M | -$158.84M | -$119.55M |
| Free cash flow | $1.04B | $798.08M | $772.88M | $384.15M | $636.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IDXX | $529.01 | +1.7% | 824.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get IDEXX Laboratories, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW